Diagnostic Applicability of Dipeptidyl Aminopeptidase IV Activity in Cytological Samples for Differentiating Follicular Thyroid Carcinoma from Follicular Adenoma

Archives of Surgery

Volumn 139, Issue 1, 2004, Pages 83-88

  Maruta, Junko ^a   Hashimoto, Hironobu ^a   Yamashita, Hiroto ^a   Yamashita, Hiroyuki ^a   Noguchi, Shiro ^a  

^a Noguchi Thyroid Clin/Hosp Found   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; THYROGLOBULIN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CYTOLOGY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; TUMOR VOLUME; ULTRASOUND;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; BIOPSY, NEEDLE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DIPEPTIDYL PEPTIDASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0346998050     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.1.83     Document Type: Article

References (31)

1. Herrera MF, Lopez CM, Saldana J, et al. Trends in thyroid surgery at the Instituto Nacional de la Nutricion Salvador Zubiran. Rev Invest Clin. 1995;47:13-19.
2. Galloway JW, Sardi A, DeConti RW, Mitchell WT Jr, Bolton JS. Changing trends in thyroid surgery: 38 years' experience. Am Surg. 1991;57:18-20.
3. Koike E, Yamashita H, Noguchi S, et al. Effect of combining ultrasonography and ultrasound-guided fine-needle aspiration biopsy findings for the diagnosis of thyroid nodules. Eur J Surg. 2001;167:656-661.
4. Kotani T, Aratake Y, Ogata Y, et al. Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett. 1991;57:203-208.
5. Aratake Y, Kotani T, Tamura K, et al. Dipeptidyl aminopeptidase IV staining of cytological preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol. 1991;96:306-310.
6. Iwabuchi H, Toriya K, Mimura T, Tamai S, Ito K, Kato H. Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid disease. Acta Cytol. 1996;40:158-163.
7. Lojda Z. Studies on glycyl-proline naphthylamidase, I: lymphocytes. Histochemistry. 1977;54:299-309.
8. Umeki K, Tanaka T, Yamamoto I, et al. Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues. Endocr J. 1996;43:53-60.
9. Kotani T, Asada Y, Aratake Y, et al. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumors. J Pathol. 1992;168:41-45.
10. Hirai K, Kotani T, Aratake Y, Ohtaki S, Kuma K. Dipeptidyl peptidase IV (DPP IV/ CD26) staining predicts distant metastasis of "benign" thyroid tumor. Pathology International. 1999;49:264-265.
11. Yamashita H. Evaluation of thyroid nodules. In: Clark OH, Noguchi S, eds. Thyroid Cancer - Diagnosis and Treatment. St Louis, Mo: Quality Medical Publishing Inc; 2000:21-37.
12. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002; 26:41-44.
13. Miltenburg DM, Prost HM, Graviss EA, Arem R. The role of frozen section, gender, age, and tumor size in the differentiation of follicular adenoma from carcinoma: a meta-analysis. Surgery. 2000;128:1075-1081.
14. Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, Sukumar S. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res. 1997;57:2144-2147.
15. Camargo RS, Scafuri AG, de Tolosa EM, Ferreira EA. DNA image cytometric analysis of differentiated thyroid adenocarcinoma specimens. Am J Surg. 1992;164:640-645.
16. Cusick EL, Ewen SWB, Krukowski ZH, Matheson NA. DNA aneuploidy in follicular thyroid neoplasia. Br J Surg. 1991;78:94-96.
17. Grant CS, Hay ID, Ryan JJ, Bergstralh EJ, Rainwater LM, Goellner JR. Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg. 1990;14:283-290.
18. Joensuu H, Klemi PJ, Eerola E. Diagnostic value of flow cytometric DNA determination combined with fine needle aspiration biopsy in thyroid tumors. Anal Quant Cytol Histol. 1987;9:328-334.
19. Shechtman L, Koren R, Horowitz A, Shechtman I, Halpern M, Gal R. Diagnostic value of AgNOR staining in thyroid cytology. Anal Quant Cytol Histol. 1998;20:187-191.
20. Zaczek M, Szot W, Chlap Z. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland. Anal Quant Cytol Histol. 1996;18:1-8.
21. Karmakar T, Dey P. Role of AgNOR in diagnosis of thyroid follicular neoplasms on fine-needle aspiration smears. Diagn Cytopathol. 1995;12:148-151.
22. Ruschoff J, Prasser C, Cortez T, Hohne HM, Hohenberger W, Hofstadter F. Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features. Am J Surg Pathol. 1993; 17:1281-1288.
23. Lean CL, Delbridge L, Russell P, et al. Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab. 1995; 80:1306-1311.
24. Somorjai RL, Nikulin AE, Pizzi N, et al. Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra, I: application to 1 H spectra of thyroid neoplasms. Magn Reson Med. 1995;33:257-263.
25. Delbridge L, Lean CL, Russell P, et al. Proton magnetic resonance and human thyroid neoplasia, II: potential avoidance of surgery for benign follicular neoplasms. World J Surg. 1994;18:512-517.
26. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance and human thyroid neoplasia, I: discrimination between benign and malignant neoplasms. Am J Med. 1994;96:383-388.
27. Yamashita H, Noguchi S, Murakami N, Adachi M, Maruta J. Immunohistological differentiation of benign thyroid follicular cell tumors from malignant ones: usefulness of anti-peroxidase and JT-95 antibodies. Acta Pathol Jpn. 1993;43:670-673.
28. Kawachi K, Matsushita Y, Yonezawa S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol. 2000;31:428-433.
29. Orlandi F, Saggiorato E, Pivano G, et al. Galection-3 is a presurgical marker of human thyroid carcinoma. Cancer Res. 1998;58:3015-3020.
30. Fernandez PL, Merino MJ, Gomez M, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol. 1997;181:80-86.
31. Cvejic D, Savin S, Panuovic I, Tatic S, Havelka M, Sinadinovic J. Immnohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res. 1998;18:2637-2641.